Strain Profile
Save

Lactobacillus johnsonii La1

◐ Food-origin
Sequenced
Public genome assembly available

Lactobacillus johnsonii La1 (also known as NCC533) is among the more extensively studied probiotic strains, with human randomized controlled trials examining several applications. Multiple RCTs have investigated its role in relation to Helicobacter pylori colonization, and separate clinical trials have examined postoperative Crohn's disease prophylaxis. In vitro and animal work has examined antimicrobial activity against Giardia intestinalis in laboratory settings, involving bile salt hydrolases. La1 has also been studied in infant formula contexts in relation to fecal microbiota composition, and in a trial in elderly hospitalized patients examining nutritional and immune status. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 52 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+2 more systems

Symptoms in the research

Share of this strain's 23 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+3 more symptoms

Research

83 papers reference this strain in the probiotic database.

Match confidence
2018 ANIMAL
Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo
· Frontiers in Microbiology
2016 ANIMAL
Role of Bile-Salts Hydrolases (BSH) of probiotic lactobacilli against giardiasis
·
2016 ANIMAL
Rôle des Bile Salt Hydrolases (BSH) des lactobacilles probiotiques dans le contrôle de la giardiose
· theses.fr (ABES)
2016 IN_VITRO
Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth
· Frontiers in Microbiology
2012 IN_VITRO
Improved Bioavailability of Dietary Phenolic Acids in Whole Grain Barley and Oat Groat following Fermentation with Probiotic Lactobacillus acidophilus, Lactobacillus johnsonii, and Lactobacillus reuteri
· Journal of Agricultural and Food Chemistry
2012 ANIMAL
Reduction of Overall Helicobacter pylori Colonization Levels in the Stomach of Mongolian Gerbil by Lactobacillus johnsonii La1 (LC1) and Its in Vitro Activities against H. pylori Motility and Adherence
· Bioscience Biotechnology and Biochemistry
2010 RCT
A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients
· World Journal of Gastroenterology
2008 RCT
Urinary D-Lactate Excretion in Infants Receiving Lactobacillus johnsonii with Formula
· Annals of Nutrition and Metabolism
2008 RCT
Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children
· Nutrition
2007 RCT
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
· Yearbook of Gastroenterology
2007 RCT
Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533)
· British Journal Of Nutrition
2007 REVIEW
Probiotics and Natural Defense Function of the Host
· Bioscience and Microflora
2006 RCT
Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1
· British Journal Of Nutrition
2006 RCT
Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants.
· PubMed
2006 RCT
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohnʼs disease after ileo-caecal resection
· Inflammatory Bowel Diseases
2006 RCT
Inefficacité du Lactobacillus johnsonii LA1 dans la prophylaxie des récidives postopératoires de la maladie de Crohn un essai GETAID contrôlé, randomisé, en double aveugle versus placebo
·
2005 RCT
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
· Gut
2005 ANIMAL
Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis In Vivo
· Infection and Immunity
2005 ANIMAL
Lactobacillus johnsonii La1 Attenuates Helicobacter pylori-Associated Gastritis and Reduces Levels of Proinflammatory Chemokines in C57BL/6 Mice
· Clinical and Vaccine Immunology
2005 IN_VITRO
GroEL of Lactobacillus johnsonii La1 (NCC 533) Is Cell Surface Associated: Potential Role in Interactions with the Host and the Gastric Pathogen Helicobacter pylori
· Infection and Immunity
Browse all 83 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients
    · World Journal of Gastroenterology · 2010
    PMID 20066735 →
  2. [2]
    Probiotics and Natural Defense Function of the Host
    · Bioscience and Microflora · 2007
    Source →
  3. [3]
    Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533)
    · British Journal Of Nutrition · 2007
    PMID 17617944 →
  4. [4]
    Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1
    · British Journal Of Nutrition · 2006
    PMID 16469146 →
  5. [5]
    Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants.
    · PubMed · 2006
    PMID 16837430 →
  6. [6]
    El CONSUMO REGULAR DE LACTOBACILLUS JOHNSONII LA1 INTERFIERE CON LA COLONIZACIÓN GÁSTRICA POR HELICOBACTER PYLORI
    · Revista chilena de nutrición · 2003
    Source →
  7. [7]
    Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man
    · European Journal of Gastroenterology & Hepatology · 2001
    PMID 11204805 →
  8. [8]
    Modulation of Nonspecific Mechanisms of Defense by Lactic Acid Bacteria: Effective Dose
    · Journal of Dairy Science · 1999
    PMID 10342225 →